Filing Flows › Connect Biopharma Holdings (CNTB) › Q2 2026 › vs Q1 2026
Connect Biopharma Holdings (CNTB) Q2 2026 vs Q1 2026 (quarter over quarter)
Connect Biopharma Holdings's revenue rose $2.6M (16×) from $169K in Q1 2026 to $2.8M in Q2 2026.
Connect Biopharma Holdings, Q2 2026: revenue $2.8M (58× year over year), operating margin -636.0%, net loss $17.3M, operating cash flow −$15.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $2.8M | $169K | $2.6M | 16× |
| Other income, net | $380K | $257K | $123K | +48% |
| Net loss | $17.3M | $19.4M | −$2.1M | -11% |
| Costs & expenses | $20.4M | $19.8M | $608K | +3% |
| Operating costs | $20.4M | $19.8M | $596K | +3% |
| Income tax | $60K | $48K | $12K | +25% |
| Research & development | $16.3M | $15.0M | $1.2M | +8% |
| General & admin | $4.1M | $4.7M | −$647K | -14% |
| Operating cash sources | $17.3M | $17.4M | −$24K | -0.1% |
| Depreciation & amortization | $161K | $164K | −$3K | -2% |
| Share-based compensation | $1.3M | $1.2M | $62K | +5% |
| Cash used in operations | $15.9M | $16.0M | −$83K | -0.5% |
| Net loss absorbed | $17.3M | $19.4M | −$2.1M | -11% |
| Working capital & other | $60K | −$2.0M | $2.1M | — |
Questions
How much did Connect Biopharma Holdings's revenue grow quarter over quarter in Q2 2026?
Connect Biopharma Holdings's revenue rose $2.6M (16×) from $169K in Q1 2026 to $2.8M in Q2 2026.